Literature DB >> 18005669

Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cells.

Dave C Francisco1, Prakash Peddi, Jessica M Hair, Brittany A Flood, Angela M Cecil, Peter T Kalogerinis, George Sigounas, Alexandros G Georgakilas.   

Abstract

Oxidatively induced stress and DNA damage have been associated with various human pathophysiological conditions, including cancer and aging. Complex DNA damage such as double-strand breaks (DSBs) and non-DSB bistranded oxidatively induced clustered DNA lesions (OCDL) (two or more DNA lesions within a short DNA fragment of 1-10 bp on opposing DNA strands) are hypothesized to be repair-resistant lesions challenging the repair mechanisms of the cell. To evaluate the induction and processing of complex DNA damage in breast cancer cells exposed to radiotherapy-relevant gamma-ray doses, we measured single-strand breaks (SSBs), DSBs, and OCDL in MCF-7 and HCC1937 malignant cells as well as MCF-10A nonmalignant human breast cells. For the detection and measurement of SSBs, DSBs, and OCDL, we used the alkaline single-cell gel electrophoresis, gamma-H2AX assay, and an adaptation of pulsed-field gel electrophoresis with E. coli repair enzymes as DNA damage probes. Increased levels for most types of DNA damage were detected in MCF-7 cells while the processing of DSBs and OCDL was deficient in these cells compared to MCF-10A cells. Furthermore, the total antioxidant capacity of MCF-7 cells was lower compared to their nonmalignant counterparts. These findings point to the important role of complex DNA damage in breast cancer and its potential association with breast cancer development especially in the case of deficient BRCA1 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005669     DOI: 10.1016/j.freeradbiomed.2007.10.045

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  18 in total

1.  Targeting abnormal DNA repair in therapy-resistant breast cancers.

Authors:  Lisa A Tobin; Carine Robert; Pratik Nagaria; Saranya Chumsri; William Twaddell; Olga B Ioffe; George E Greco; Angela H Brodie; Alan E Tomkinson; Feyruz V Rassool
Journal:  Mol Cancer Res       Date:  2011-11-23       Impact factor: 5.852

2.  DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells.

Authors:  Prakash Peddi; Charles W Loftin; Jennifer S Dickey; Jessica M Hair; Kara J Burns; Khaled Aziz; Dave C Francisco; Mihalis I Panayiotidis; Olga A Sedelnikova; William M Bonner; Thomas A Winters; Alexandros G Georgakilas
Journal:  Free Radic Biol Med       Date:  2010-03-01       Impact factor: 7.376

Review 3.  The role of histone modifications and variants in regulating gene expression in breast cancer.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-04       Impact factor: 2.673

Review 4.  Encoding and decoding cellular information through signaling dynamics.

Authors:  Jeremy E Purvis; Galit Lahav
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

5.  Cell fate decision mediated by p53 pulses.

Authors:  Xiao-Peng Zhang; Feng Liu; Zhang Cheng; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

6.  Accumulation of oxidatively induced clustered DNA lesions in human tumor tissues.

Authors:  Somaira Nowsheen; Rebecca L Wukovich; Khaled Aziz; Peter T Kalogerinis; Christopher C Richardson; Mihalis I Panayiotidis; William M Bonner; Olga A Sedelnikova; Alexandros G Georgakilas
Journal:  Mutat Res       Date:  2008-10-02       Impact factor: 2.433

7.  Controversial BRCA1 allelotypes in commonly used breast cancer cell lines.

Authors:  Sivasundaram Karnan; Morassa Mohseni; Yuko Konishi; Akina Tamaki; Yoshitaka Hosokawa; Ben H Park; Hiroyuki Konishi
Journal:  Breast Cancer Res Treat       Date:  2009-07-08       Impact factor: 4.872

8.  Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance.

Authors:  Robert G Lingeman; Robert J Hickey; Linda H Malkas
Journal:  Cancer Chemother Pharmacol       Date:  2014-09-05       Impact factor: 3.333

9.  Radiosensitizing activity of a novel Benzoxazine through the promotion of apoptosis and inhibition of DNA repair.

Authors:  Suraj Radhamani; Christopher Bradley; Terri Meehan-Andrews; Saleh K Ihmaid; Jasim Al-Rawi
Journal:  Invest New Drugs       Date:  2014-03-14       Impact factor: 3.850

10.  Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer.

Authors:  Lidia Delrieu; Marina Touillaud; Olivia Pérol; Magali Morelle; Agnès Martin; Christine M Friedenreich; Pauline Mury; Armelle Dufresne; Thomas Bachelot; Pierre-Etienne Heudel; Béatrice Fervers; Olivier Trédan; Vincent Pialoux
Journal:  Oxid Med Cell Longev       Date:  2021-07-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.